Overview The first FDA-approved treatment for equine protozoal myeloencephalitis (EPM).

  • Ponazuril, the active ingredient, crosses the blood/brain barrier to reach the central nervous system where it kills Sarcocystis neurona
  • Precalibrated oral dosing syringe ensures accurate delivery of each dose
  • Easy to administer correctly; the horse owner can give the full dose each time